SCHEMBL24927331

SCHEMBL24927331

N#Cc1ccc(C#N)c(-c2c3ccccc3c(-c3ccccc3)c3ccccc23)c1-c1cccc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 3/20 0.37
MAOA P21397 3/20 0.35
TSHR P16473 2/20 0.33
MAOB P27338 2/20 0.33
IMPDH2 P12268 1/20 0.33
HTR3A P46098 1/20 0.33
MEN1 O00255 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
IL1R1 P14778 1/20 0.32
STAT3 P40763 1/20 0.32
HIF1A Q16665 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24926961 0.93 KDM4E (0.37) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927268 0.88 KDM4E (0.44) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927460 0.88 KDM4E (0.46) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927273 0.88 KDM4E (0.41) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24926977 0.88 KDM4E (0.41) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24926838 0.88 KDM4E (0.41) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927270 0.87 ATM (0.42) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927134 0.87 KDM4E (0.38) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24927072 0.86 KDM4E (0.40) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2
SCHEMBL24926836 0.85 ATM (0.41) L3MBTL1KDM4EATMALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-21 US disclosed
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-25 US disclosed
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165130-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP2E1, AOX1 L3MBTL1 650/4885KDM4E 2489/4885ATM 3438/4885
US-20230174560-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 L3MBTL1 830/4885KDM4E 3046/4885ATM 3302/4885
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME NR0B1, CRY1, CCNT1 L3MBTL1 124/4885KDM4E 4020/4885ATM 1651/4885
US-20230301179-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CRY1, AOX1, CYP1A1 L3MBTL1 1020/4885KDM4E 2808/4885ATM 3264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.